International safety notice
Technical Name: Gentamicin (Diagnostic Products for in vitro use)
Brazil / Anvisa · BRA · Jun 13, 2016
Key facts
| Title | Technical Name: Gentamicin (Diagnostic Products for in vitro use) |
|---|---|
| Regulator | Brazil / Anvisa |
| Country | BRA |
| Brand | Commercial Name: GENT2 ONLINE TDM GENTAMICIN (Diagnostic Products for in vitro use) ///registration 10287410655/// risk class II (Products that present medium risk to the user or patient and low risk to public health)//Lot 11916601 (distributed 2 in São Paulo-SP and 1 in Porto Velho-RO). |
| Manufacturer | DETENTOR DO REGISTRO DO PRODUTO NO BRASIL ROCHE DIAGNÓSTICA BRASIL LTDACNPJ 30280358000186 AVENIDA ENGENHEIRO BILLINGS 1729 PRÉDIO 38 SÃO PAULO SP TEL 08007720295 FABRICANTE ROCHE DIAGNOSTICS GMBH SANDHOFER STRASSE 116 68305 ALEMANHA |
| Models | 11916601, 10287410655, GENT2 |
| Date | Jun 13, 2016 |
| Regulator page | anvisa.gov.br |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1